baber/WOPTO huggingface dataset:
Patent DK-0466651-T3 (DK)
Inventor: SCHEUCHZER ANTOINE PASCAL
IPC: E01B29/16
Filed: 1991-07-05
Granted: 1996-01-02
Abstract: The new rails to be laid are heated continuously in order to be neutralized. For this purpose, they are raised and exposed to a source of heat in the form of two heating tunnels which are mounted on a vehicle running in a continuous manner on the old rails. Each heating tunnel is traversed by a stretch of new rail. Simultaneously, the old rails are detached from the sleepers, and, after the passage of the vehicle, are deposited along the track or are cleared away. The heating vehicle is followed by an assembly vehicle by means of which the new rails, brought to and maintained at the temperature of neutralization, are laid continuously on the sleepers and are fastened thereto. In front of the heating vehicle, there is provided, on the old track, a welding vehicle for welding the new rails.
Patent DK-0597834-T3 (DK)
Inventor: PEERY JOHN R
IPC: A61K9/52
Filed: 1991-01-18
Granted: 1996-02-26
Abstract: A dispensing device is disclosed for delivering a beneficial agent. The device comprises (1) a semipermeable housing defining a internal space, (2) an optional and presently preferred in the space, (3) a heat responsive composition comprising a beneficial agent in the space, (4) a space consuming member in the device, (5) a non-toxic compound blended with the heat responsive composition for enhancing its viscosity; (6) an exit port in the wall for increasing the internal pressure of the dispenser and for simultaneously letting the beneficial agent exit through said port from the device, and (7) an embodiment comprising a prehydrating fluid for fastening the start-up of delivery from the delivery system.
Patent DK-0494294-T3 (DK)
Inventor: BURNIE JAMES PETER
IPC: C12R1/15
Filed: 1991-07-25
Granted: 1994-11-14
Abstract: The present invention relates to a purified stress protein of 86 Kd and fragments thereof isolated from the genus Corynebacterium. Particular fragments include those with apparent molecular weights of 50 Kd and 52 Kd. The stress protein has been found to be an immunodominant conserved antigen. Patients with Corynebacterium jeikeium septicemia or endocarditis have antibody to the 52 Kd breakdown product. The protein cross-reacts with a peptide antigen KVIRKNIVKKMIE (see SEQ ID No. 1) using a mouse monoclonal antibody against the peptide. The stress protein is useful for improved diagnosis, monitoring and treatment of Corynebacterium infections and diseases.
Patent DK-0524624-T3 (DK)
Inventor: MCDANIEL MAX PAUL
IPC: C07C63/331
Filed: 1992-07-23
Granted: 2002-08-26
Abstract: Fluorenyl-containing metallocenes are disclosed along with methods for making the metallocenes. Also disclosed are methods for using the metallocenes as polymerization catalysts. In addition, polymers resulting from such polymerizations are disclosed. <IMAGE>
Patent DK-0546726-T3 (DK)
Inventor: TRUSCOTT JIM
IPC: A61F2/38
Filed: 1992-11-27
Granted: 1997-03-10
Abstract: There is disclosed a prosthetic knee joint which comprises: a bicompartmental femoral component (1) capable of attachment to a femur and having a lateral and a medial articular bearing surface (4); a bicompartmental tibial component (20) capable of attachment to a tibia and having a medial (26) and a lateral (27) articular bearing surface; and a bicompartmental meniscal component (11) capable of acting as a bearing positioned between the bearing surfaces of the femoral (1) and tibial (20) components, wherein the tibial component (20) is provided between its medial (26) and lateral (27) articular bearing surfaces with a protruding member (22) having at least at its distal end a cross-sectional shape which has a parallel-sided intermediate region extending between two convexly arcuate end regions, and wherein the meniscal component (11) is provided with a recess (13) in which the protruding member (22) of the tibial component can be accommodated with play. <IMAGE>
Patent DK-0584620-T3 (DK)
Inventor: DAUPHIN FRIEDRICH WILHELM
IPC: A47C1/032
Filed: 1993-08-09
Granted: 1996-10-21
Abstract: A chair, in particular office chair, is provided with a foot stand (1), with a seat support (4) which is supported thereon by means of a chair column (3) and has a front and a rear seat-support part (12, 13) connected to one another via a pivot pin (20), with a seat (5) supported on the seat-support parts (12, 13), with a back (7) fixed to the rear seat-support part (13) and with an energy storing device (gas spring 27) which is articulated on the seat-support parts (12, 13) at a distance from their pivot pin (20), is adjustable in length and is intended for mutual adjustment of back (7) and seat (5), one seat-support part (12) being equipped with a receptacle (bearing block 47) for the upper end of the chair column (3). The receptacle (bearing block 47) on the seat-support part (12) is articulated via an articulation pin (49) arranged parallel to the pivot pin (20) of front and rear seat-support parts (12, 13). In order to lock and release various inclinations of the seat support (4) with respect to the chair column (3), the seat-support part (12) is provided with a locking device which is operative between the seat-support part (12) and the receptacle (bearing block 47). <IMAGE>
Patent DK-0590355-T3 (DK)
Inventor: DE SIMONE CLAUDIO DR
IPC: A61K31/22
Filed: 1993-09-06
Granted: 1998-03-02
Abstract: A novel therapeutical utilization of L-carnitine, acyl L-carnitines and the pharmacologically acceptable salts thereof is disclosed, for treating immune and metabolic alterations in patients suffering from AIDS and AIDS-related syndromes and in asymptomatic HIV-seropositive patients. The L-carnitine amount to be administered according to this novel use is about 6-8 grams daily, via the oral route or an equivalent amount of an acyl L-carnitine or a pharmacologically acceptable salt thereof, i.e. three-four times as much the dose usually administered for the already known therapeutic uses of L-carnitine.
Patent DK-0589336-T3 (DK)
Inventor: LANG HANS-JOCHEN DR
IPC: C07D211/14
Filed: 1993-09-14
Granted: 1997-06-16
Abstract: The invention relates to benzoylguanidines of the formula I <IMAGE> where R(1) or R(2) is equal to R(3)-S(O)n- or R(4)R(5)N-O2S- and the other substituent R(1) or R(2) is in each case equal to H, OH, F, Cl, Br, I, alkyl, alkoxy, benzyloxy or phenoxy, R(3)-S(O)n or R(4)R(5)N- or 3,4-dehydropiperidine and R(3) is equal to alkyl, cycloalkyl, cyclopentylmethyl, cyclohexylmethyl or phenyl, R(4) and R(5) are equal to alkyl or phenylalkyl or phenyl, and in which R(4) and R(5) together can also be a C4-C7-chain, and in which R(4) and R(5), together with the nitrogen atom to which they are bonded, can denote a dihydroindol, tetrahydroquinoline or tetrahydroisoquinoline system,  and where n is equal to zero, 1 or 2 and their pharmaceutically tolerable salts are outstanding antiarrhythmic agents. They are obtained by a process in which compounds of the formula II <IMAGE> in which X stands for a leaving group which can be easily nucleophilically substituted, are reacted with guanidine.
Patent DK-0608525-T3 (DK)
Inventor: BEHRINGER REINHARD
IPC: A23L1/305
Filed: 1993-12-10
Granted: 1997-08-25
Abstract: Milk composition based on the natural constituents of milk and having greatly reduced sodium, potassium and citrate contents. The composition has organoleptic properties which are enhanced with respect to milk, characterised by increased sweetness and a pure and fresh taste, as well as a greater whiteness than that of evaporated milk.
Patent DK-0577544-T3 (DK)
Inventor: EBERLE MARCEL KARL
IPC: A61K38/00
Filed: 1993-02-22
Granted: 1997-04-01
Abstract: Cyclosporins wherein the residue at the 1-position has the formula I   <CHEM> in which -x-y- is -CH=CH-(trans) or -CH2-CH2-, X is 0 or S and R is hydrogen, optionally halo or hydroxy substituted-C1-3-alkyl, -alkoxy or -alkylthio, or amino or mono- or di-(C1-2alkyl)-amino, useful as pharmaceuticals, preferentially for topical administration in particular for asthma therapy.
Patent DK-0606046-T3 (DK)
Inventor: MACPHERSON LAWRENCE J
IPC: A61K31/415
Filed: 1993-12-21
Granted: 1998-05-04
Abstract: Compounds of formula I <CHEM> wherein R, R1, R2 and Ar are as defined in the description, have valuable pharmaceutical properties and are effective especially as matrix metalloproteinase inhibitors, for example for the treatment of arthritis. They are prepared in a manner known per se.
Patent DK-0662836-T3 (DK)
Inventor: WINICOV MURRAY W
IPC: A61K38/18
Filed: 1993-09-16
Granted: 2000-04-17
Abstract: Stable, aqueous detergent-iodine germicidal use compositions and concentrates adapted for application to animal or human skin are provided which have desirable detergent:iodine ratios of from about 2-4.5. The compositions and concentrates include a polyethoxylated polyoxypropylene block copolymer (poloxamer) as the complexing agent, wherein the polyoxypropylene moiety has an average molecular weight of at least 2600 and a polyoxyethylene content of from about 30%-75% by weight, in combination with from about 0.1%-5% by weight average available iodine on a nominal basis. Use of the defined class of poloxamers allows formulation of both high and low temperature stable compositions and concentrates. Other ingredients such as emollients, buffering agents and viscosity improvers can also form a part of the use compositions and concentrates.
Patent DK-0667860-T3 (DK)
Inventor: HARRIS PAUL JOHN THE BOOTS COM
IPC: A61P25/24
Filed: 1993-10-23
Granted: 1999-05-25
Abstract: PCT No. PCT/EP93/02951 Sec. 371 Date Apr. 28, 1995 Sec. 102(e) Date Apr. 28, 1995 PCT Filed Oct. 23, 1993 PCT Pub. No. WO94/11346 PCT Pub. Date May 26, 1994Compounds of formula I    <IMAGE>  I  and pharmaceutically acceptable salts thereof in which m is an integer from 1 to 3; n is an integer from 2 to 6; R1 is phenyl optionally substituted by one or more substituents selected from halo, hydroxy, alkoxy, alkanoyl, alkyl, halogenated alkyl, alkylthio, alkylsulphinyl, alkylsulphonyl, cyano, nitro, optionally substituted amino, optionally substituted sulphamoyl, optionally substituted carbamoyl or phenyl, or R1 is naphthyl; R2 is H, alkyl or phenyl; R3 is H, alkyl, alkenyl or alkoxyalkyl; R4 is H or hydroxy; and R5 is H or together with R4 represents a bond; have utility in the treatment of obesity and affective disorders such as depression and anxiety.
Patent DK-0659957-T3 (DK)
Inventor: OSTHEIMER TIBOR
IPC: B62H3/00
Filed: 1994-10-08
Granted: 1998-03-16
Abstract: The box-like garage unit exhibits two side walls 1 which are connected with the aid of a cover part 3 and of a foot panel or tray 4. At least one side is provided, adjoining the cover part 3, with a foot part 5 and backrest 6, the seat part 5 being adjoined by a door part 7, and the parts 5, 6, 7 being arranged on the cover part 3 in a hinge-like manner. The interior formed by the garage unit is suitable for receiving a bicycle 29. <IMAGE>
Patent DK-0652723-T3 (DK)
Inventor: HEER ALFRED
IPC: A47L13/512
Filed: 1994-05-11
Granted: 1997-08-18
Abstract: PCT No. PCT/CH94/00087 Sec. 371 Date Jan. 27, 1995 Sec. 102(e) Date Jan. 27, 1995 PCT Filed May 11, 1994 PCT Pub. No. WO94/27487 PCT Pub. Date Dec. 8, 1994The invention concerns a device comprising at least one clamp (1) to hang up a substantially elongated object. The clamp is displaceable toward a wall or another clamp (1) in order that the object be held in-between on account of its own weight. The minimum of one clamp furthermore comprises two vertically spaced rest segments (3, 5) and/or at least one planar rest zone in order to engage one side of the object being clamped or suspended and to drive this object against the wall or the other clamp.
Patent DK-0698018-T3 (DK)
Inventor: SZENTE LAJOS
IPC: A61K47/48
Filed: 1994-05-09
Granted: 2003-02-10
Abstract: The present invention relates to an active inclusion complex of Taxol, Taxotere or a Taxus extract formed with a cyclodextrin-derivative, a pharmaceutical composition containing the same, a process of preparation and a method of treatment.
Patent DK-0659219-T3 (DK)
Inventor: RUEF HARTMUT
IPC: D04H3/14
Filed: 1994-07-08
Granted: 1996-06-17
Abstract: PCT No. PCT/AT94/00087 Sec. 371 Date Jan. 4, 1995 Sec. 102(e) Date Jan. 4, 1995 PCT Filed Jul. 8, 1994 PCT Pub. No. WO95/02082 PCT Pub. Date Jan. 19, 1995Disclosed is a process for producing cellulose fibers having a decreased tendency to fibrillate. The process comprises the steps of extruding a solution of cellulose in a tertiary amine-oxide through spinning holes of a spinneret to form cellulose filaments, conducting the extruded cellulose filaments across an air gap of greater than 30 mm, and introducing the cellulose filaments into a precipitation bath. The process is carried out in a way that the mathematical expression 51.4+0.033xD+1937xM2 -7.18xT-0.094xL-2.50xF+0.045xF2, does not exceed the number 10. In the mathematical expression, D is the spinning hole diameter in  mu m, M is the dope output per hole in g/min, T is the titer of the individual filament in dtex, L is the length of the air gap in mm and F is the humidity of the air in the air gap in g of water/kg of air.
Patent DK-0779175-T3 (DK)
Inventor: DREXLER JOHANNES HERMAN
IPC: B60N2/28
Filed: 1996-12-03
Granted: 1999-11-08
Abstract: An infant safety seat of the type, comprising a bucket seat body (1) having a supporting bottom and a pivotable carrying handle and provided with attachment points for the hip belt portion and the shoulder belt portion respectively of a threepoints-safety belt (8). Between the support bottom surface and the seat surface thereabove there is a transverse through belt receiving space adjacent the front side of the bucket seat body (1), said space being delimited at the front side by a transverse and upstanding belt holding surface, that is accessible for a belt from an end of the bucket seat body (1). <IMAGE>
Patent DK-0781887-T3 (DK)
Inventor: CLARAC ANDRE
IPC: E01C19/10
Filed: 1996-12-19
Granted: 2002-12-09
Abstract: The system for obtaining dense cold bituminous coating comprises a mixer (1), transportation (2) for the addition of large elements, transportation (5) for the addition of fine elements (GF), transportation (4) for adding a first emulsion and transportation (6) for the second emulsion. Large elements (GG) are introduced into the mixer. A measured first emulsion (EBPF) is then introduced to obtain a homogeneous and uniform binding film on the large elements. A measured second emulsion (ES-BPF) is introduced to obtain a total coating of the mixture. The second emulsion is obtained from the first emulsion during mixing by adding a cationic aqueous agent (SV). This cationic agent comprises additives which enable obtaining a second emulsion with a viscosity between 3 and 1000 STV. The cationic agent is measured in the ratio of 0.5 to 2% of the mixture of large elements and fine elements.
Patent DK-0811165-T3 (DK)
Inventor: HAAHEIM LARS REINHARDT
IPC: G01N33/15
Filed: 1996-02-21
Granted: 2000-05-08
Abstract: PCT No. PCT/GB96/00392 Sec. 371 Date Aug. 21, 1997 Sec. 102(e) Date Aug. 21, 1997 PCT Filed Feb. 21, 1996 PCT Pub. No. WO96/26443 PCT Pub. Date Aug. 29, 1996The present invention provides a method of detecting active antibody production in a blood sample by contacting, in the presence and absence of protein synthesis inhibitor, aliquots of the sample with a solid phase under conditions which permit antibody production and secretion by the lymphocytes; detecting in solution, binding of antibody to the antigen(s) on the solid phase; and comparing the antibody binding in the presence or absence of protein synthesis inhibitor, whereby to obtain a determination of the amount of active antibody secretion in response to the antigen(s); and kits for performing the method. The method may also be modified to allow detection of non-specific infection indicators.
Patent DK-0818030-T3 (DK)
Inventor: PUTTKAMMER FRANK
IPC: G07D7/02
Filed: 1996-03-29
Granted: 1999-06-07
Abstract: The invention concerns a method and devices for checking security documents. According to this process which uses known capacitive coupling, electrical signals are transmitted by transmitting antennae via electrically conductive security features to receiving antennae and amplified. The amplitude responses and time characteristics of the electrical signals are then evaluated and compared with existing signal responses, by being converted into signal responses having easily comparable parameters. In order to enable the testing arrangement to be specifically selective, a selective amplifier is additionally coupled to the evaluation electronics. Currency-specific definition by means of the evaluation electronics according to the invention is attained in that, for a given currency, a time limit of the test signal amplitude can be determined by means of controllers, for example, this time limit differing from the duration of the amplitude response of all the other currencies.
Patent DK-0820308-T3 (DK)
Inventor: MAIER-BORST WOLFGANG
IPC: A61K41/00
Filed: 1996-04-12
Granted: 2001-11-12
Abstract: This invention relates to the use of a conjugate comprising an active substance and a native protein which is not recognized as foreign protein for the production of a pharmaceutical preparation for treating and/or diagnosing inflammatory, infectious and/or skin diseases.
Patent DK-0821118-T3 (DK)
Inventor: WESSELS BERNHARD
IPC: E04F10/06
Filed: 1997-04-24
Granted: 2003-11-17
Abstract: In a joint-arm awning comprising two joint arms disposed on a support pipe, it being possible by fastening brackets to join the support pipe to the wall of a housing, and devices being provided for adjustment of the angle of inclination of the awning in order to constructionally simplify the adjustment of the angle of inclination and obtain defined retraction conditions regardless of the adjusted angle of inclination, that the support pipe is substantially round, having a longitudinal groove, with which engages a locking element for adjustment of the angle of inclination.
Patent DK-0915842-T3 (DK)
Inventor: THATCHER GREGORY R
IPC: C07C327/28
Filed: 1997-05-30
Granted: 2004-07-26
Abstract: Aliphatic Nitrate esters having a sulfur or phosphorus atom  beta  or  gamma  to a nitrate group having efficacy as vasodilators are described. Preferred nitrate esters may be synthesized by nitration of a 3-bromo-1,2-propanediol, and subsequent reaction to yield the desired mono, di or tetra nitrate ester.
Patent DK-0932175-T3 (DK)
Inventor: WECKE ROLF DIPL-ING
IPC: H01H11/00
Filed: 1998-07-11
Granted: 2006-01-23
Abstract: A radius actuator including an actuating member having a shaft which projects into the holder and carries the ball on that end. The ball is fixedly clamped into a clamping part which consists of two halves connected with one another by screws and which is situated in a hollow chamber of the holder. A spring is between the clamping part and the holder in the hollow chamber. The holder is provided with two mounting bores which lead into the hollow chamber and are alignable with the screws of the clamping part.
Patent DK-1005538-T3 (DK)
Inventor: MELMAN ARNOLD
IPC: A61K48/00
Filed: 1998-02-05
Granted: 2005-11-07
Abstract: The present invention is directed towards gene therapy for erectile dysfunction through delivery and expression of a recombinant vector containing a DNA sequence encoding a protein involved in the regulation of smooth muscle tone into a smooth muscle cell. Also provided by the present invention is a method of inducing penile erection in a subject comprising the introduction and expression of a DNA sequence encoding a protein involved in the regulation of smooth muscle tone into a sufficient number of cells of the subject to induce penile erection in the subject. The present invention also provides a recombinant vector comprising the DNA of or corresponding to at least a portion of the genome of a virus, which portion is capable of directing the expression of a DNA sequence, and DNA encoding a protein involved in the regulation of smooth muscle tone operably linked to the viral DNA and capable of being expressed as a functional gene product in the target cell. Also provided by the present invention is a smooth muscle cell which expresses a gene encoding a protein involved in the regulation of smooth muscle tone.
Patent DK-0947256-T3 (DK)
Inventor: RUPOLI SIMONE
IPC: B21D3/02
Filed: 1999-03-22
Granted: 2004-01-05
Abstract: An apparatus for straightening metal profiled elements, particularly iron rods, comprising pairs of wheels (3,4) arranged in series, with parallel axes, on opposite sides with respect to a plane along which one or more side-by-side rods (2) to be straightened are fed. At an output region, the apparatus has a first split wheel (20) and a second split wheel (21), which are arranged in series and are adapted to cooperate with respective contrarotating wheels (3,4). Each one of the split wheels is constituted by at least a pair of wheels (22,23) arranged side by side which are adapted to be engaged respectively by the side-by-side rods (2) and are provided with an independent adjustment of the position of the axis in a direction which is perpendicular to the feed plane of the rods. <IMAGE>
Patent DK-0955049-T3 (DK)
Inventor: WINKLEY MICHAEL WILLIAM
IPC: A61P9/10
Filed: 1995-04-28
Granted: 2004-10-11
Abstract: A process for the production of medrogestone, in which, in an intermediate step, the solvate 3 beta ,5 alpha ,6 beta -trihydroxy-6 alpha ,17 alpha -dimethylpregnan-20-one monomethanolate is obtained as a solid, stable compound by displacing the organic solvent from a solution of of 3 beta ,5 alpha ,6 beta -trihydroxy-6 alpha ,17 alpha -dimethylpregnan-20-one with a lower alkanol, and a Diels-Alder adduct of 6-methylene-17 alpha -methylpregn-4-ene-3,20-dione with maleic anhydride is used as an intermediate for production of the corresponding dicarboxylic acid salt for removal of 6-methylene-17 alpha -methylpregn-4-ene-3,20-dione contamination of the desired product. Another intermediate, 6 beta -hydroxy-6 alpha ,17 alpha -dimethylpregn-4-ene-3,20-dione, has been found to prevent smooth muscle proliferation and is useful in the treatment of atherosclerosis and restinosis.
Patent DK-1137452-T3 (DK)
Inventor: LULLA AMAR
IPC: A61M15/00
Filed: 1999-03-18
Granted: 2005-11-14
Abstract: A spacer device for an inhaler is made of a non-metallic antistatic material, preferably polyamide. The device may comprise two frustoconical members joined at their wider ends, with an inlet and outlet at, respectively, the two narrower ends. A measured dose of medicament is injected through the inlet, and then inhaled from the chamber through the outlet.
Patent DK-1144367-T3 (DK)
Inventor: O'BRIEN MICHAEL K
IPC: C07C261/00
Filed: 1999-12-17
Granted: 2005-01-31
Abstract: Methods for stereoselective substitution in which a (mono or un)-alpha-substituted unprotected beta-amino ester compound or salt thereof is reacted with an aliphatic electrophile in the presence of a base selected from alkyl lithium compounds, lithium hydride, lithium amide, lithium dialkyl amides and alkali hexamethyldisilylamines.
Patent ES-2251907-T3 (ES)
Title: Dispositivo de soporte para componentes de construccion prefabricados hechas de hormigon o similars, con una elevada resistencia a los terremotos.
Inventor: ZAMBELLI SERGIO
IPC: E04B2/94
Filed: 2000-05-19
Granted: 2006-05-16
Abstract: Un dispositivo de soporte para componentes prefabricados de construcción, particularmente para unidades prefabricadas hechas de hormigón o similares, comprendiendo un asiento en forma de casquillo (2a, 2b, 2c) que está formado en una cara (3) de una primera unidad (4) y un elemento de soporte (5a, 5b, 5c) que está insertado separablemente en dicho asiento y tiene un extremo que sobresale de dicho asiento (2a, 2b, 2c) y de dicha cara (3) de la primera unidad (4) y forma una región de descanso (6a, 6b, 6c) para una segunda unidad (7), caracterizado por el hecho de que comprende medios amortiguadores (30, 31, 33, 40, 50) que están interpuestos entre dicho elemento de soporte (5a, 5b, 5c) y dicha primera unidad (4) y entre dicho elemento de soporte (5a, 5b, 5c) y dicha segunda unidad (7).